Literature DB >> 3285713

Repeat parathyroid operation associated with renal disease.

P T Alexander1, E S Schuman, R M Vetto, G F Gross, J F Hayes, B A Standage.   

Abstract

One hundred ten patients who had undergone operation for secondary and tertiary hyperparathyroidism have been described. Ninety patients had secondary disease and 20 patients had tertiary disease after renal transplantation. From these two groups, 18 patients had repeat operations for control of recurrent or persistent disease. The incidence of repeat operations was 14 percent. Causes were graft-dependent hyperparathyroidism, supernumerary glands in the neck or mediastinum, and incomplete identification of glands in the neck. The most important risk factor is continued long-term dialysis in functionally anephric patients. We recommend that patients with hyperparathyroidism associated with chronic renal failure undergo total parathyroidectomy with autotransplantation. If repeat operation is necessary, a reduction in glandular mass with autotransplantation is preferred. In selected patients, total parathyroidectomy can be considered because of the increased risk of aluminum bone disease.

Entities:  

Mesh:

Year:  1988        PMID: 3285713     DOI: 10.1016/s0002-9610(88)80145-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma.

Authors:  Peter F Nichol; James R Starling; Eberhard Mack; Jason J Klovning; Bryan N Becker; Herbert Chen
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

2.  Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial.

Authors:  M Rothmund; P K Wagner; C Schark
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

3.  Parathyroidectomy for hyperparathyroidism associated with renal disease.

Authors:  D P O'Leary; H J White
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.